Overview
- Sigma Healthcare confirmed on Monday that it had “elected to withdraw its interest and cease discussions immediately,” saying a Boots acquisition would not meet its strategic or capital-investment objectives.
- The withdrawal leaves Wittington Investments, the Weston family vehicle, as the only reported private bidder still in talks over a deal widely pegged at about £7.5bn.
- Boots’s owner Sycamore Partners is continuing to weigh options, including a possible London initial public offering, as the company prepares under incoming CEO Alex Baldock.
- Boots has reported recent improvement in performance, with roughly £7.5bn in revenue and a 25% rise in pre-tax profit to £337m, factors that will shape investor appetite for a float or sale.
- Sigma’s exit and the market reaction — Sigma shares jumped about 6% — sharpen the wider stakes for the London market and leave investors watching whether the Westons will bid or Sycamore will pursue a high-profile UK listing.